English / Industries / Health Care_Xinhua Finance Agency

Novartis freezes drug prices, but its Gleevec already unaffordable

Novartis freezes drug prices, but its Gleevec already unaffordable

2018-07-20 13:55

Novartis, the European pharmaceutical giant, was praised by U.S. President Donald Trump on Thursday after deciding against raising drug prices.

Chinas new Alzheimers drug completes phase 3 clinical trial

China's new Alzheimer's drug completes phase 3 clinical trial

2018-07-18 10:16

A Chinese research group on Tuesday announced progress in developing a drug to treat Alzheimer's disease.

Chinese drug maker recalls valsartan products in U.S. over impurity

Chinese drug maker recalls valsartan products in U.S. over impurity

2018-07-18 09:08

Zhejiang Huahai Pharmaceutical has halted the supply of valsartan to the U.S. market and may face losses.

Global healthcare leader Sanofi sets up innovation center in SW China

Global healthcare leader Sanofi sets up innovation center in SW China

2018-07-04 09:43

French pharmaceutical company Sanofi signed a cooperation agreement to establish its Operation and Innovation Center in Chengdu.

Chinese government encourages innovation of medical devices

Chinese government encourages innovation of medical devices

2018-07-04 09:32

The National Drug Administration of China (NDAC) is encouraging the innovation of medical devices.

China speeds up price reduction on cancer drugs

China speeds up price reduction on cancer drugs

2018-07-02 09:19

China has included 15 more clinically effective yet expensive cancer medicines into its list of medical insurance reimbursement.

Australian vitamin-maker to build Shanghai R&D center

Australian vitamin-maker to build Shanghai R&D center

2018-06-27 10:15

Australian health supplements maker Blackmores Ltd is building its first overseas research and development center in Shanghai.

Tencent releases first AI-aided medical platform

Tencent releases first AI-aided medical platform

2018-06-24 20:50

The Chinese tech giant, Tencent Holdings Ltd. released its first artificial intelligence-aided medical diagnosis and treatment open platform.

Chinas FDA approves new drug for treating HIV

China's FDA approves new drug for treating HIV

2018-06-08 16:12

China Food and Drug Administration (FDA) has approved the sale of a new drug for the treatment of HIV-1 infection, the maker of the drug said.

Chinese fund invests in British surgical robot

Chinese fund invests in British surgical robot

2018-06-06 14:22

CMR Surgical has raised 100 million U.S. dollars in funding from five investors including the Zhejiang SilkRoad Fund in China.

Shanghai Kinetic Medical injects RMB495mln to purchase Elliquence

Shanghai Kinetic Medical injects RMB495mln to purchase Elliquence

2018-06-06 11:18

Shanghai Kinetic Medical plans to invest 77.15 million U.S.dollars via its wholly-owned subsidiary to purchase 100 percent stakes of Elliquence, LLC.

AI is helping to transform the way elderly people are cared for

AI is helping to transform the way elderly people are cared for

2018-05-22 14:57

In the U.K., one business, Cera, is using technology to offer care services for older people who require assistance with day-to-day living.

1
2
3
4
5

Editor's Choice

US lifts export ban on suppliers to China's ZTE

China Tower eyes $10b HK offering

China's central SOEs see decline in debt-asset ratio in H1

Consumers suffer most in tariff escalation: U.S. expert

China's capital market opening-up attracts foreign asset management firms

China raises anti-dumping duties on U.S. optical fiber

Guideline to help lift financial security, mixed ownership

CEINEX sets D-share market standards for Chinese Company

Don't Miss

China’s cross-border capital liquidity stays stably in H1

Chinese firms goes deep debt, so comes the defaults

Biotech IPO boom comes with side effects

The future of Chinese equity market

China Stock Market
A Shares

| About Us | Advertise on Site | Contact Us | Job Offer | Copyright Statement | Disclaimer Statement | Copyright |

All materials posted on this website marked with “Source: Xinhua Finance Agency” are subject to copyrights owned by the Xinhua Finance Agency (XFA). Any reproduction, retransmissions, or republication of all or part of any document found on this website is expressly prohibited, unless XFA has explicitly granted its prior written consent. All other rights reserved.Although XFA website includes "links" providing convenient direct access to other Internet sites, XFA does not endorse, approve, certify or make warranties or representations as to the accuracy of the information on these sites.

All financial data and news content of this website is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to any investment decision. Opinions contained in this website represent those of XFA at the time of publication and are subject to changes.XFA will make reasonable efforts to include accurate and up to date information on XFA website, but XFA makes no warranties or representations as to its accuracy, adequacy or completeness, and shall not be liable for any direct, incidental, consequential, indirect or punitive damages arising out of access to, use of or inability to use XFA website, or any errors or omissions in the content thereof.

Copyright © 2015 - Xinhua Finance Agency Ltd. All rights reserved.
For best performance, please use IE version 10 or above to visit our website.